Gastrointestinal Cancer News

ATLANTA — Intrapleurally administered, mesothelin-targeted chimeric antigen receptor T cells demonstrated antitumor activity without major toxicity among patients with malignant pleural disease from mesothelioma, according to results of a phase 1 trial presented at American Association for Cancer Research Annual Meeting.

Researchers are launching a multi-institutional trial to test the effectiveness of precise, higher dose, MRI-guided radiation therapy to treat pancreatic cancer.

A recent analysis showed that mortality from intrahepatic cholangiocarcinoma has increased globally while mortality from extrahepatic cholangiocarcinoma has leveled off or decreased.

Antoni Ribas, MD, PhD, has been elected president-elect of American Association for Cancer Research for the 2019-2020 term.

Stereotactic ablative radiotherapy safely extended long-term survival for some patients with oligometastatic cancer, according to results from a prospective phase 2 trial published in International Journal of Radiation Oncology Biology Physics.

Results from a randomized clinical trial suggest that $10 is not enough to motivate people to return their fecal immunochemical tests for colorectal cancer screening.

In contrast to current reports that show liver cancer rates increasing on the global scale, the incidence of hepatocellular carcinoma remained stable for 18 years in a large German cohort study.

The risk for hepatocellular carcinoma was statistically significantly reduced by 29% in patients with hepatitis B virus who received daily aspirin, according to findings published in JAMA Internal Medicine.

Infertile women appeared more likely to develop certain malignancies than women without fertility problems, according to an analysis of a U.S. insurance claims database.

The FDA approved trastuzumab-qyyp for the treatment of HER2-overexpressing breast cancer and metastatic gastric or gastroesophageal junction adenocarcinoma.